Spontaneous low-frequency fluctuations in the neural system for emotional perception in major psychiatric disorders: amplitude similarities and differences across frequency bands

Conclusion: We found subtle disturbances in body-ownership experiences in patients with schizophrenia, which were associated with delusions. We found no evidence for impairments in children/adolescents at increased familial risk of developing schizophrenia or a mood disorder. Longitudinal data might reveal whether impairments in body ownership are predictive of psychosis onset. PMID: 30525317 [PubMed - as supplied by publisher]
Source: Journal of Psychiatry and Neuroscience - Category: Psychiatry Tags: J Psychiatry Neurosci Source Type: research

Related Links:

ConclusionThese results confirm the significant association between rs11038167 and rs835784 and rs11038172 polymorphisms and increased risk of schizophrenia in Iranian population suggested earlier in previous studies on Han Chinese population.
Source: Meta Gene - Category: Genetics & Stem Cells Source Type: research
Publication date: Available online 22 August 2019Source: Pharmacological ResearchAuthor(s): Chuanhong Luo, Xiaorong Xu, Xichuan Wei, Wuwen Feng, Haozhou Huang, Haiyan Liu, Runchun Xu, Junzhi Lin, Li Han, Dingkun ZhangAbstractIt is a common phenomenon that people are in a sub-health condition and facing “unexplained fatigue”, which seriously affects their health, work efficiency and quality of life. Meanwhile, fatigue is also a common symptom of many serious diseases such as HIV/AIDS, cancer, and schizophrenia. However, there are still no official recommendations for the treatment of various forms of fatigue. So...
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
AbstractThe aim of the study was to assess rates of severe parkinsonism related to different antipsychotic drugs (APDs) using data from an observational pharmacovigilance programme in German-speaking countries —Arzneimittelsicherheit in der Psychiatrie (AMSP). Data on APD utilization and reports of severe APD-induced parkinsonism were collected in 99 psychiatric hospitals in Austria, Germany and Switzerland during the period 2001–2016. Of 340,099 patients under surveillance, 245,958 patients were trea ted with APDs for the main indications of schizophrenic disorders, depression, mania and organic mental disorde...
Source: European Archives of Psychiatry and Clinical Neuroscience - Category: Neuroscience Source Type: research
Source: European Archives of Psychiatry and Clinical Neuroscience - Category: Neuroscience Source Type: research
Conclusions: In terms of the primary objective, the relatively low dropout rate observed in the present study suggests that SCIT is feasible and well tolerated by patients with schizophrenia in Japan. This view is also supported by participants’ relatively high attendance and intrinsic motivation.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Conditions:   Schizophrenia;   Psychosis Interventions:   Behavioral: Cognitive behavioural family intervention (CBFI);   Behavioral: Usual group psychoeducation Sponsors:   Hospital Authority, Hong Kong;   The University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Schizophrenia Intervention:   Drug: Paliperidone Palmitate Sponsor:   Huazhong University of Science and Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Schizophrenia;   Psychosis Interventions:   Behavioral: Cognitive behavioural family intervention (CBFI);   Behavioral: Usual group psychoeducation Sponsors:   Hospital Authority, Hong Kong;   The University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Schizophrenia Intervention:   Drug: Paliperidone Palmitate Sponsor:   Huazhong University of Science and Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This post was originally posted on the Cochrane Methods websiteIn January 2018, the FDAannounced a pilot aimed at enhancing the transparency of the Agency's drug approval process and decisions. As part of the pilot, sponsors of up to nine drug applications to the FDA were asked, on a voluntary basis, if they would approve the public release of portions of the CSRs, which would be posted within an Action Package for the drug that also includes FDA application review files and letters. The parts of the CSRs made publicly available included information from the study report body, the protocol and amendments, and the statistic...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news
More News: Brain | Child Development | Children | Neurology | Psychiatry | Schizophrenia